Hematological and infectious complications with CD38 antigen targeting monoclonal antibody-based therapies in multiple myeloma: A meta-analysis of randomized control trials. Leuk Res 2021 Nov;110:106714
Date
10/02/2021Pubmed ID
34598075DOI
10.1016/j.leukres.2021.106714Scopus ID
2-s2.0-85115920018 (requires institutional sign-in at Scopus site) 2 CitationsAuthor List
Yarlagadda N, Gundarlapalli S, Sharma S, Suelzer E, Abid MB, Abdallah AO, Schinke C, Atrash S, Mohan MAuthor
Test W. User test user title in the Anesthesiology department at Medical College of WisconsinMESH terms used to index this publication - Major topics in bold
ADP-ribosyl Cyclase 1Antibodies, Monoclonal
Communicable Diseases
Hematologic Diseases
Humans
Multiple Myeloma
Prognosis
Randomized Controlled Trials as Topic